Sielaff, Catherine M.
Mousa, Shaker A.
Article History
Received: 29 January 2018
Accepted: 23 April 2018
First Online: 2 May 2018
Compliance with ethical standards
:
: S.A.M. holds stock in a small pharmaceutical company, NanoPharmaceuticals LLC, that is developing anticancer drugs. C.S. has no conflicts to declare.
: This article does not contain any studies with human participants or animals performed by any of the authors.